News related to Halfan (Halofantrine) and/or conditions it is approved for
Insights Into Process Of Malarial Drug Resistance
Source: Genetics News From Medical News Today [2008.11.27]
Malaria, one of the oldest diseases known to man, has shown no signs of slowing down as it ages. More than 1 million children die from malaria in sub-Saharan Africa each year, and in areas along the Thailand/Cambodian border multiple drug-resistant strains of the disease are becoming commonplace.
Combination Therapies May Be Almost As Effective As Insecticide-treated Bednets In Preventing Malaria In Areas Of Low Transmission
Source: Tropical Diseases News From Medical News Today [2008.11.27]
Artemisinin combination therapies (ACTs) could be almost as effective in reducing transmission of malaria as insecticide-treated bednets (ITNs) in areas of low transmission, a study based on data from Tanzania has found. In high transmission areas, long-acting antimalarial regimens may be needed to achieve significant transmission reductions.
Babies are Africa's malaria warriors (Reuters)
Source: Y! Health News Search RSS Feed [2008.11.27]
Reuters - For a footsoldier on the cutting-edge of a global public health experiment, Michael Kenyali was looking a little wobbly.
ACTs May Achieve Malaria Transmission Reductions Comparable To Insecticide Treated Nets In Low Transmission Settings In Tanzania
Source: Tropical Diseases News From Medical News Today [2008.11.25]
In low-transmission areas, if widely used, artemisinin combination therapy (ACT) may reduce malaria transmission as effectively as the widespread use of insecticide-treated bed nets, says a new study published in next week's PLoS Medicine.
New Technologies Gearing Up To Meet Rising Demand For Vital Malaria Drugs
Source: Tropical Diseases News From Medical News Today [2008.11.19]
Three emerging technologies have the potential to significantly improve supplies of drugs to combat malaria, according to a report just published. With renewed efforts to eradicate malaria - a disease which kills up to one million people every year, most of them young children - the global demand for antimalarials is set to increase dramatically over the next four years.
90 Million African Children Still Exposed To Malaria, Despite Net Usage Increase
Source: Aid / Disasters News From Medical News Today [2008.11.18]
The use of insecticide-treated bed nets (ITNs) to protect children from malaria has risen six-fold in the past seven years, according to research funded by the Wellcome Trust. Despite this success, however, 90 million children still do not have access to this simple protective tool, and remain at risk from the life-threatening disease. Malaria kills nearly a million people in Africa every year.
Interpol Seizes $6.65M In Counterfeit HIV/AIDS, Malaria, TB Drugs In Southeast Asia
Source: Litigation / Medical Malpractice News From Medical News Today [2008.11.18]
The International Criminal Police Organization recently confiscated $6.65 million worth of counterfeit HIV/AIDS, malaria and tuberculosis drugs in Southeast Asia and made 27 arrests as part of a five-month investigation involving nearly 200 raids, Aline Plancon, an officer involved in the operation, said on Monday,
Drug Forecasting Method For Anti-Malarial Treatments To Be Presented At The American Society Of Tropical Medicine And Hygiene Annual Meeting
Source: Tropical Diseases News From Medical News Today [2008.11.18]
Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases. While this may sound simple, ensuring a sufficient supply of effective drugs to each country that needs them remains a challenge until the demand for those drugs is accurately predicted and understood.
IMM, Cenix, And Alnylam Discover New Targets In Malaria Infection With RNAi Technology
Source: Tropical Diseases News From Medical News Today [2008.11.13]
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Cenix BioScience GmbH, a leading RNAi-focused contract research organization, today announced the publication of a new study in the journal PLoS Pathogens demonstrating in vitro and in vivo RNAi-mediated silencing of novel host factors involved in malaria infection. The work resulted from an ongoing malaria research program started as a collaboration announced in 2005 between the group of Dr.
'Airport Malaria' A Cause For Concern In The US
Source: Tropical Diseases News From Medical News Today [2008.11.12]
In a global world, significant factors affect the spread of infectious diseases, including international trade, air travel and globalized food production. "Airport malaria" is a term coined by researchers to explain the more recent spread of malaria to areas such as the United States and Europe, which some scientists credit to warmer climate changes.
Novel Antibiotic Class Also Active Against Malaria Parasite
Source: Tropical Diseases News From Medical News Today [2008.11.05]
A new class of antimicrobial agent with broad-spectrum activity has been found to kill Plasmodium falciparum, the parasite that causes the most lethal form of human malaria. University of Pennsylvania pharmacologist Doron Greenbaum, Ph.D., presented these results, from in vitro experiments, at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held in Washington, D.C. from October 25-28. Dr.
Genetic Research Offers Insights Into Form of Malaria
Source: MedicineNet Malaria Specialty [2008.10.09]
Title: Genetic Research Offers Insights Into Form of Malaria
Category: Health News
Created: 10/9/2008 2:00:00 AM
Last Editorial Review: 10/9/2008
Malaria
Source: MedicineNet Alpha Thalassemia Specialty [2008.01.14]
Title: Malaria
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 1/14/2008
World Leaders In Infectious Diseases To Convene And Discuss Developments In Research, Prevention And Treatment
Source: Conferences News From Medical News Today [2008.11.15]
Nearly 2,900 physicians and scientists from institutions around the world such as the World Health Organization, the Centers for Disease Control and the National Institutes of Health will meet at the 57th American Society of Tropical Medicine and Hygiene's Annual Meeting Dec. 7-11, in New Orleans to discuss the latest research on infectious and emerging diseases and global health threats. Meeting highlights include: "Airport Malaria" - Cause for Concern in the U.S.
Global Fund Grants Nearly $3B For HIV/AIDS Efforts
Source: Tropical Diseases News From Medical News Today [2008.11.12]
The Global Fund To Fight AIDS, Tuberculosis and Malaria on Monday announced it has approved nearly $3 billion in Round 8 funding to improve access to HIV treatment and prevention and help reduce deaths from TB and malaria by 50% by 2015, AFP/Yahoo! News reports (AFP/Yahoo! News, 11/10).
Zimbabwe Returns $7.3M In Misused Grant Money To Global Fund
Source: Tropical Diseases News From Medical News Today [2008.11.10]
The Reserve Bank of Zimbabwe has returned $7.3 million in misused grant money to the Global Fund To Fight AIDS, Tuberculosis and Malaria, Global Fund Executive Director Michel Kazatchkine said Friday, Reuters reports (Williams, Reuters [1], 11/7).The money, which was part of last year's $12.
Malawi Receives $20M Grant To Bolster HIV Treatment, Testing Efforts
Source: Tropical Diseases News From Medical News Today [2008.11.07]
A senior government official on Wednesday announced that Malawi has received a $20 million grant from the Global Fund To Fight AIDS, Tuberculosis and Malaria to expand its HIV/AIDS treatment and testing program, AFP/Yahoo! News reports.
|
